Pathways is a collaborative research group dedicated to advancing equitable cancer care through patient engagement, inclusive research practices, and implementation science. Our mission is to create and evaluate sustainable, evidence-based strategies that improve health outcomes and quality of life for individuals living with and beyond cancer, with a particular focus on underserved and diverse populations. By bridging research, practice, and lived experience, Pathways aims to illuminate and transform the complex journeys of cancer care, ensuring that every individual has access to person-centred care that is effective and inclusive.

Projects

Exploring the perspectives of stakeholders for homologous recombination deficient (HRD) biomarker testing to guide precision medicine for advanced ovarian cancer treatment

HRD testing is an effective biomarker test for the treatment management for advanced ovarian cancer. Currently, HRD testing is not funded publicly for all individuals in Canada.

Leads
Helen McTaggart-Cowan

Members

Faculty/Leaders

Staff

Dr. Kelcey Bland, PhD

Postdoctoral Researcher
Send message

Students/Trainees

Back to top